{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:44:47Z","timestamp":1787499887940,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"DOI":"10.1186\/s12905-026-04288-3","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T14:09:29Z","timestamp":1769004569000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A clinicopathological study of borderline ovarian tumors: insights from a tertiary care center in Saudi Arabia"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0427-8758","authenticated-orcid":false,"given":"Saeed","family":"Baradwan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan M.","family":"Latifah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bandr","family":"Hafedh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haneen","family":"Al-Maghrabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruzanah","family":"Almarzugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wajd","family":"Aljabri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa","family":"Edrees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"4288_CR1","unstructured":"Sutton GP. Ovarian tumors of low malignant potential. Ovarian cancer 2nd ed Philadelphia: Lippincott Williams & Wilkins. 2001:399\u2013417."},{"issue":"Suppl 1","key":"4288_CR2","first-page":"S161","volume":"95","author":"AP Heintz","year":"2006","unstructured":"Heintz AP, Odicino F, Maisonneuve P et al. Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006;95(Suppl 1):S161\u201392.","journal-title":"Int J Gynaecol Obstet"},{"issue":"3","key":"4288_CR3","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.bpobgyn.2011.12.006","volume":"26","author":"CG Trope","year":"2012","unstructured":"Trope CG, Kaern J, Davidson B. Borderline ovarian tumours. Best Pract Res Clin Obstet Gynaecol. 2012;26(3):325\u201336.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"Suppl 1","key":"4288_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/ijgo.13878","volume":"155","author":"JS Berek","year":"2021","unstructured":"Berek JS, Renz M, Kehoe S, et al. Cancer of the ovary, fallopian tube, and peritoneum: 2021 update. Int J Gynaecol Obstet. 2021;155(Suppl 1):61\u201385.","journal-title":"Int J Gynaecol Obstet"},{"issue":"Suppl 1","key":"4288_CR5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/ijgo.70282","volume":"171","author":"M Renz","year":"2025","unstructured":"Renz M, Friedlander M, Berek JS. Cancer of the ovary, fallopian tube, and peritoneum: 2025 update. Int J Gynaecol Obstet. 2025;171(Suppl 1):6\u201335.","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"4288_CR6","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ejca.2005.07.029","volume":"42","author":"P Morice","year":"2006","unstructured":"Morice P. Borderline tumours of the ovary and fertility. Eur J Cancer. 2006;42(2):149\u201358.","journal-title":"Eur J Cancer"},{"issue":"09","key":"4288_CR7","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1055\/s-0029-1186007","volume":"69","author":"B du Ad","year":"2009","unstructured":"du Ad B, Ewald-Riegler N, Du Bois O, et al. Borderline tumors of the ovary-a systematic review. Geburtshilfe Frauenheilkd. 2009;69(09):807\u201333.","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"12","key":"4288_CR8","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1634\/theoncologist.2012-0139","volume":"17","author":"D Fischerova","year":"2012","unstructured":"Fischerova D, Zikan M, Dundr P, et al. Diagnosis, treatment, and follow-up of borderline ovarian tumors. Oncologist. 2012;17(12):1515\u201333.","journal-title":"Oncologist"},{"issue":"4","key":"4288_CR9","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3802\/jgo.2015.26.4.343","volume":"26","author":"SJ Seong","year":"2015","unstructured":"Seong SJ, Kim DH, Kim MK, et al. Controversies in borderline ovarian tumors. J Gynecol Oncol. 2015;26(4):343\u20139.","journal-title":"J Gynecol Oncol"},{"issue":"7","key":"4288_CR10","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1586\/era.10.90","volume":"10","author":"F Trillsch","year":"2010","unstructured":"Trillsch F, Mahner S, Ruetzel J, et al. Clinical management of borderline ovarian tumors. Expert Rev Anticancer Ther. 2010;10(7):1115\u201324.","journal-title":"Expert Rev Anticancer Ther"},{"issue":"5","key":"4288_CR11","first-page":"471","volume":"30","author":"C Trope","year":"2009","unstructured":"Trope C, Davidson B, Paulsen T, et al. Diagnosis and treatment of borderline ovarian neoplasms the state of the art. Eur J Gynaecol Oncol. 2009;30(5):471\u201382.","journal-title":"Eur J Gynaecol Oncol"},{"issue":"5","key":"4288_CR12","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1002\/cncr.20080","volume":"100","author":"ME Sherman","year":"2004","unstructured":"Sherman ME, Mink PJ, Curtis R, et al. Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis. Cancer. 2004;100(5):1045\u201352.","journal-title":"Cancer"},{"issue":"8","key":"4288_CR13","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1016\/j.ejca.2013.01.035","volume":"49","author":"A du Bois","year":"2013","unstructured":"du Bois A, Ewald-Riegler N, de Gregorio N, et al. Borderline tumours of the ovary: A cohort study of the Arbeitsgmeinschaft Gynakologische Onkologie (AGO) Study Group. Eur J Cancer. 2013;49(8):1905\u201314.","journal-title":"Eur J Cancer"},{"key":"4288_CR14","doi-asserted-by":"publisher","first-page":"100756","DOI":"10.1016\/j.gore.2021.100756","volume":"36","author":"S Kumari","year":"2021","unstructured":"Kumari S, Kumar S, Bhatla N, et al. Oncologic and reproductive outcomes of borderline ovarian tumors in Indian population. Gynecol Oncol Rep. 2021;36:100756.","journal-title":"Gynecol Oncol Rep"},{"key":"4288_CR15","doi-asserted-by":"publisher","first-page":"962820","DOI":"10.3389\/fsurg.2022.962820","volume":"9","author":"K Gaballa","year":"2022","unstructured":"Gaballa K, Abdelkhalek M, Fathi A, et al. Management of borderline ovarian tumors: A tertiary referral center experience in Egypt. Front Surg. 2022;9:962820.","journal-title":"Front Surg"},{"issue":"1","key":"4288_CR16","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13048-023-01107-3","volume":"16","author":"B Kipp","year":"2023","unstructured":"Kipp B, Vidal A, Lenick D, et al. Management of Borderline ovarian tumors (BOT): results of a retrospective, single center study in Switzerland. J Ovarian Res. 2023;16(1):20.","journal-title":"J Ovarian Res"},{"issue":"1","key":"4288_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","volume":"124","author":"J Prat","year":"2014","unstructured":"Prat J, Oncology FCG. Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet. 2014;124(1):1\u20135.","journal-title":"Int J Gynaecol Obstet"},{"issue":"10","key":"4288_CR18","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1055\/s-0035-1558079","volume":"75","author":"I Meinhold-Heerlein","year":"2015","unstructured":"Meinhold-Heerlein I, Fotopoulou C, Harter P, et al. Statement by the Kommission Ovar of the AGO: The New FIGO and WHO Classifications of Ovarian, Fallopian Tube and Primary Peritoneal Cancer. Geburtshilfe Frauenheilkd. 2015;75(10):1021\u20137.","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"3","key":"4288_CR19","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1097\/00003081-200609000-00011","volume":"49","author":"MB Jones","year":"2006","unstructured":"Jones MB. Borderline ovarian tumors: current concepts for prognostic factors and clinical management. Clin Obstet Gynecol. 2006;49(3):517\u201325.","journal-title":"Clin Obstet Gynecol"},{"issue":"5","key":"4288_CR20","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1097\/00000478-199105000-00001","volume":"15","author":"RH Young","year":"1991","unstructured":"Young RH, Gilks CB, Scully RE. Mucinous tumors of the appendix associated with mucinous tumors of the ovary and pseudomyxoma peritonei. A clinicopathological analysis of 22 cases supporting an origin in the appendix. Am J Surg Pathol. 1991;15(5):415\u201329.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"4288_CR21","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/PAS.0000000000000535","volume":"40","author":"NJ Carr","year":"2016","unstructured":"Carr NJ, Cecil TD, Mohamed F, et al. A Consensus for Classification and Pathologic Reporting of Pseudomyxoma Peritonei and Associated Appendiceal Neoplasia: The Results of the Peritoneal Surface Oncology Group International (PSOGI) Modified Delphi Process. Am J Surg Pathol. 2016;40(1):14\u201326.","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"4288_CR22","first-page":"277","volume":"48","author":"K Nyangoh-Timoh","year":"2020","unstructured":"Nyangoh-Timoh K, Bendifallah S, Dion L, et al. Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Value of Tumor Markers. Gynecol Obstet Fertil Senol. 2020;48(3):277\u201386.","journal-title":"Gynecol Obstet Fertil Senol"},{"issue":"8","key":"4288_CR23","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1111\/IGC.0b013e3181a83e04","volume":"19","author":"E Kolwijck","year":"2009","unstructured":"Kolwijck E, Thomas CM, Bulten J, et al. Preoperative CA-125 levels in 123 patients with borderline ovarian tumors: a retrospective analysis and review of the literature. Int J Gynecol cancer: official J Int Gynecol Cancer Soc. 2009;19(8):1335\u20138.","journal-title":"Int J Gynecol cancer: official J Int Gynecol Cancer Soc"},{"issue":"8","key":"4288_CR24","doi-asserted-by":"publisher","first-page":"5795","DOI":"10.1245\/s10434-025-17518-z","volume":"32","author":"M Tonello","year":"2025","unstructured":"Tonello M, Cenzi C, Pizzolato E, et al. National Guidelines for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Peritoneal Malignancies: A Worldwide Systematic Review and Recommendations of Strength Analysis. Ann Surg Oncol. 2025;32(8):5795\u2013806.","journal-title":"Ann Surg Oncol"},{"issue":"Suppl 1","key":"4288_CR25","doi-asserted-by":"publisher","first-page":"i20","DOI":"10.1093\/annonc\/mdw090","volume":"27","author":"A du Bois","year":"2016","unstructured":"du Bois A, Trillsch F, Mahner S, et al. Management of borderline ovarian tumors. Ann Oncol. 2016;27(Suppl 1):i20\u20132.","journal-title":"Ann Oncol"},{"issue":"2","key":"4288_CR26","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ygyno.2014.02.013","volume":"133","author":"M Van Kleppe","year":"2014","unstructured":"Kleppe M, Bruls J, Van Gorp T, et al. Mucinous borderline tumours of the ovary and the appendix: a retrospective study and overview of the literature. Gynecol Oncol. 2014;133(2):155\u20138.","journal-title":"Gynecol Oncol"},{"issue":"6","key":"4288_CR27","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1007\/s00404-016-4174-y","volume":"294","author":"S De Cosyns","year":"2016","unstructured":"Cosyns S, De Sutter P, Tournaye H, et al. Necessity of appendectomy for mucinous borderline ovarian tumors. Systematic review. Arch Gynecol Obstet. 2016;294(6):1283\u20139.","journal-title":"Arch Gynecol Obstet"},{"issue":"9","key":"4288_CR28","first-page":"CD007696","volume":"2010","author":"O Faluyi","year":"2010","unstructured":"Faluyi O, Mackean M, Gourley C, et al. Interventions for the treatment of borderline ovarian tumours. Cochrane Database Syst Rev. 2010;2010(9):CD007696.","journal-title":"Cochrane Database Syst Rev"},{"key":"4288_CR29","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.bpobgyn.2016.09.012","volume":"41","author":"DM Gershenson","year":"2017","unstructured":"Gershenson DM. Management of borderline ovarian tumours. Best Pract Res Clin Obstet Gynaecol. 2017;41:49\u201359.","journal-title":"Best Pract Res Clin Obstet Gynaecol"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-026-04288-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-026-04288-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-026-04288-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T11:54:44Z","timestamp":1771242884000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12905-026-04288-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4288"],"URL":"https:\/\/doi.org\/10.1186\/s12905-026-04288-3","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"assertion":[{"value":"24 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving humans were approved by the Ethics Committee of the Institutional Review Board of King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia (IRB approval number: 2251209). The studies were conducted in accordance with local legislation and institutional requirements, as well as the Declaration of Helsinki. The requirement for informed consent was waived by the aforementioned ethics committee due to the retrospective nature of the study, which involved anonymized analysis of existing medical records without additional interventions. All data were handled in compliance with patient confidentiality guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"103"}}